KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | -7.5% | 6,824 | +7.1% | 0.00% | 0.0% |
| Q2 2023 | $67 | -20.2% | 6,373 | -7.2% | 0.00% | 0.0% |
| Q1 2023 | $84 | -18.4% | 6,870 | -17.6% | 0.00% | 0.0% |
| Q4 2022 | $103 | -99.9% | 8,339 | +3.0% | 0.00% | 0.0% |
| Q3 2022 | $111,000 | -24.5% | 8,095 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $147,000 | +19.5% | 8,016 | +4.8% | 0.00% | 0.0% |
| Q1 2022 | $123,000 | -50.8% | 7,650 | -13.4% | 0.00% | -88.9% |
| Q1 2021 | $250,000 | -19.9% | 8,831 | -7.6% | 0.01% | -25.0% |
| Q4 2020 | $312,000 | +23.3% | 9,555 | +15.8% | 0.01% | +9.1% |
| Q3 2020 | $253,000 | – | 8,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |